EUVIMEDEUVIMED entdecken
Crossref

Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis

Kazuaki Kameda iD, Ryo Yanagiya iD, Yuji Miyatake iD, Joaquim Carreras iD, Hiroshi Higuchi, Hiromichi Murayama, Takashi Ishida iD, Asahi Ito, Shinsuke Iida iD, Noriko Fukuhara iD, Hideo Harigae, Yuki Fujioka iD und 17 weitere

Blood Journal · 2023

DOI: 10.1182/blood.2022018597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Journal, 2023. Verfasst von Kazuaki Kameda und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Leukemia, Large Granular Lymphocytic, Leukemia, Prolymphocytic, T-Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggressive natural killer cell leukemia (ANKL) is a rare lymphoid neoplasm frequently associated with Epstein-Barr virus, with a disastrously poor prognosis. Owing to the lack of samples from patients with ANKL and relevant murine models, comprehensive investigation of its pathogenesis including the tumor microenvironment (TME) has been hindered. Here we established three ANKL-patient-derived xenograft mice (PDXs), which enabled extensive analysis of tumor cells and their TME. ANKL cells primarily engrafted and proliferated in the hepatic sinusoid. Hepatic ANKL cells were characterized by an enriched Myc-pathway and proliferated faster than those in other organs. Interactome analyses and in vivo CRISPR-Cas9 analyses revealed transferrin (Tf)-transferrin receptor 1 (TfR1) axis as a potential molecular interaction between the liver and ANKL. ANKL cells were rather vulnerable to iron deprivation. PPMX-T003, a humanized anti-TfR1 monoclonal antibody, showed remarkable therapeutic efficacy in a preclinical setting using ANKL-PDXs. These findings indicate that the liver, a non-canonical hematopoietic organ in adults, serves as a principal niche for ANKL, and that inhibition of the Tf-TfR1 axis is a promising therapeutic strategy for ANKL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsLeukemia, Large Granular LymphocyticLeukemia, Prolymphocytic, T-CellAnimalsHumansMiceCell ProliferationHerpesvirus 4, HumanLiverTransferrinsTumor MicroenvironmentReceptors, TransferrinAntigens, CD

Substanzen

TransferrinsCD71 antigenReceptors, TransferrinAntigens, CD

Autor:innen und Institutionen

  • Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
  • Department of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Department of Neurology, Hematology, Diabetology, Endocrinology, and Metabolism (3rd Department of Internal Medicine), Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Department of Dermatology, Center for Cancer Immunology and Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical…

ORCID-Profile: Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, Joaquim Carreras, Takashi Ishida, Shinsuke Iida, Noriko Fukuhara, Yuki Fujioka, Naoto Takahashi, Hidenori Wada, Hideyuki Nakazawa, So Nakagawa, Ai Kotani

Zitieren

APA

Kameda, K., Yanagiya, R., Miyatake, Y., Carreras, J., Higuchi, H., Murayama, H., Ishida, T., Ito, A., Iida, S., Fukuhara, N., Harigae, H., Fujioka, Y., Takahashi, N., Wada, H., Ishida, F., Nakazawa, H., Ishihara, R., Murakami, Y., Tagawa, H., …, & Kotani, A. (2023). Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis. Blood Journal. https://doi.org/10.1182/blood.2022018597

Vancouver

Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, et al. Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis. Blood Journal. 2023. doi:10.1182/blood.2022018597

BibTeX
@article{Kameda2023,
  author = {Kameda, Kazuaki and Yanagiya, Ryo and Miyatake, Yuji and Carreras, Joaquim and Higuchi, Hiroshi and Murayama, Hiromichi and Ishida, Takashi and Ito, Asahi and Iida, Shinsuke and Fukuhara, Noriko and Harigae, Hideo and Fujioka, Yuki and Takahashi, Naoto and Wada, Hidenori and Ishida, Fumihiro and Nakazawa, Hideyuki and Ishihara, Rei and Murakami, Yuki and Tagawa, Hiroyuki and Matsuura, Tadashi and Nakagawa, So and Iwabuchi, Sadahiro and Hashimoto, Shinichi and Imadome, Ken-Ichi and Nakamura, Naoya and Ishizawa, Kenichi and Kanda, Yoshinobu and Ando, Kiyoshi and Kotani, Ai},
  title = {Hepatic niche leads to aggressive natural killer cell leukemia proliferation through transferrin-transferrin receptor 1 axis},
  journal = {Blood Journal},
  year = {2023},
  doi = {10.1182/blood.2022018597}
}
Kostenlos starten →